Yoko Tanaka

3.9k total citations · 1 hit paper
80 papers, 2.9k citations indexed

About

Yoko Tanaka is a scholar working on Pathology and Forensic Medicine, Psychiatry and Mental health and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Yoko Tanaka has authored 80 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Pathology and Forensic Medicine, 22 papers in Psychiatry and Mental health and 18 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Yoko Tanaka's work include Vitamin D Research Studies (33 papers), Attention Deficit Hyperactivity Disorder (19 papers) and Growth Hormone and Insulin-like Growth Factors (14 papers). Yoko Tanaka is often cited by papers focused on Vitamin D Research Studies (33 papers), Attention Deficit Hyperactivity Disorder (19 papers) and Growth Hormone and Insulin-like Growth Factors (14 papers). Yoko Tanaka collaborates with scholars based in United States, Japan and Germany. Yoko Tanaka's co-authors include Hector F. DeLuca, Walter E. Stumpf, Madhabananda Sar, Frederic A. Reid, Michael F. Holick, Nobuo Ikekawa, L. Castillo, Heinrich K. Schnoes, H P Kind and Donald Fraser and has published in prestigious journals such as Science, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

Yoko Tanaka

78 papers receiving 2.7k citations

Hit Papers

Target Cells for 1,25-Dihydroxyvitamin D 3 in Intestinal ... 1979 2026 1994 2010 1979 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Target Cells for 1,25-Dihydroxyvitamin D 3 in Intestinal Tract, Stomach, Kidney, Skin, Pituitary, and Parathyroid
    1979 575 citations Yoko Tanaka, Hector F. DeLuca et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yoko Tanaka United States 28 1.6k 580 503 388 386 80 2.9k
Keisuke Fukuo Japan 29 347 0.2× 372 0.6× 199 0.4× 57 0.1× 227 0.6× 181 3.1k
Nunziata Morabito Italy 21 572 0.4× 423 0.7× 411 0.8× 100 0.3× 210 0.5× 42 1.9k
Keizo Ohnaka Japan 31 336 0.2× 649 1.1× 530 1.1× 44 0.1× 137 0.4× 123 3.6k
William G. Christen United States 41 497 0.3× 255 0.4× 176 0.3× 81 0.2× 822 2.1× 103 5.5k
Ken‐ichi Aihara Japan 29 294 0.2× 682 1.2× 347 0.7× 29 0.1× 281 0.7× 117 2.8k
H. Karimi Kinyamu United States 24 571 0.4× 128 0.2× 359 0.7× 45 0.1× 199 0.5× 37 1.9k
A. Louis Southren United States 35 369 0.2× 1.4k 2.3× 473 0.9× 79 0.2× 63 0.2× 115 3.5k
Gary M. Leong Australia 27 300 0.2× 716 1.2× 477 0.9× 39 0.1× 109 0.3× 74 2.3k
Paul E. Kroeger United States 24 506 0.3× 126 0.2× 162 0.3× 31 0.1× 375 1.0× 38 2.3k
Mikiko Ito Japan 31 373 0.2× 78 0.1× 946 1.9× 140 0.4× 790 2.0× 119 3.5k

Countries citing papers authored by Yoko Tanaka

Since Specialization
Citations

This map shows the geographic impact of Yoko Tanaka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoko Tanaka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoko Tanaka more than expected).

Fields of papers citing papers by Yoko Tanaka

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yoko Tanaka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoko Tanaka. The network helps show where Yoko Tanaka may publish in the future.

Co-authorship network of co-authors of Yoko Tanaka

This figure shows the co-authorship network connecting the top 25 collaborators of Yoko Tanaka. A scholar is included among the top collaborators of Yoko Tanaka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yoko Tanaka. Yoko Tanaka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Gang, Hui Quan, Fei Chen, et al.. (2020). Lessons Learned From Multi-regional Trials With Signals of Treatment Effect Heterogeneity. Therapeutic Innovation & Regulatory Science. 54(1). 21–31. 1 indexed citations
2.
Li, Gang, Hui Quan, Fei Chen, et al.. (2018). Lessons Learned From Multi-regional Trials With Signals of Treatment Effect Heterogeneity. Therapeutic Innovation & Regulatory Science. 3593040094–3593040094. 1 indexed citations
3.
Tanaka, Yoko, Rodrigo Escobar, & Himanshu P. Upadhyaya. (2017). Assessment of effects of atomoxetine in adult patients with ADHD: consistency among three geographic regions in a response maintenance study. ADHD Attention Deficit and Hyperactivity Disorders. 9(2). 113–120. 3 indexed citations
4.
Fijal, Bonnie A., Yingying Guo, Jonna Ahl, et al.. (2015). CYP2D6 predicted metabolizer status and safety in adult patients with attention‐deficit hyperactivity disorder participating in a large placebo‐controlled atomoxetine maintenance of response clinical trial. The Journal of Clinical Pharmacology. 55(10). 1167–1174. 18 indexed citations
5.
Tanaka, Yoko, et al.. (2015). What Is a Clinically Relevant Improvement in Quality of Life in Adults With ADHD?. Journal of Attention Disorders. 23(1). 65–75. 7 indexed citations
6.
Upadhyaya, Himanshu P., Yoko Tanaka, Ludmila Kryzhanovskaya, et al.. (2015). Time-to-onset and -resolution of adverse events before/after atomoxetine discontinuation in adult patients with ADHD. Postgraduate Medicine. 127(7). 677–685. 10 indexed citations
7.
Upadhyaya, Himanshu P., Christopher J. Kratochvil, Jaswinder K. Ghuman, et al.. (2014). Efficacy and Safety Extrapolation Analyses for Atomoxetine in Young Children with Attention-Deficit/Hyperactivity Disorder. Journal of Child and Adolescent Psychopharmacology. 25(10). 799–809. 10 indexed citations
8.
Tanaka, Yoko, Luís Augusto Rohde, Ling Jin, Peter D. Feldman, & Himanshu P. Upadhyaya. (2013). A Meta-analysis of the Consistency of Atomoxetine Treatment Effects in Pediatric Patients with Attention-Deficit/Hyperactivity Disorder from 15 Clinical Trials Across Four Geographic Regions. Journal of Child and Adolescent Psychopharmacology. 23(4). 262–270. 16 indexed citations
9.
Chen, Joshua, Hao Zheng, Hui Quan, et al.. (2013). Graphical assessment of consistency in treatment effect among countries in multi-regional clinical trials. Clinical Trials. 10(6). 842–851. 6 indexed citations
10.
Robinson, Michael J., David V. Sheehan, Paula J. Gaynor, et al.. (2013). Relationship between major depressive disorder and associated painful physical symptoms. International Clinical Psychopharmacology. 28(6). 330–338. 11 indexed citations
11.
Upadhyaya, Himanshu P., Lenard A. Adler, Miguel Casas, et al.. (2013). Baseline characteristics of European and non-European adult patients with attention deficit hyperactivity disorder participating in a placebo-controlled, randomized treatment study with atomoxetine. Child and Adolescent Psychiatry and Mental Health. 7(1). 14–14. 12 indexed citations
12.
Binkowitz, Bruce, et al.. (2011). Results of a Survey of PhRMA Member Companies on Practices Associated with Multiregional Clinical Trials. Drug Information Journal. 45(5). 609–617. 1 indexed citations
13.
Asawa, Yukiyo, Yuko Fujihara, Yoko Tanaka, et al.. (2010). The Effects of Rapid- or Intermediate-Acting Insulin on the Proliferation and Differentiation of Cultured Chondrocytes. Current Aging Science. 3(1). 26–33. 8 indexed citations
14.
Hazell, Philip, Katja Becker, Paula T. Trzepacz, et al.. (2009). Relationship between atomoxetine plasma concentration, treatment response and tolerability in attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder. ADHD Attention Deficit and Hyperactivity Disorders. 1(2). 201–210. 23 indexed citations
15.
Tanaka, Yoko, Motoichiro Kato, Taro Muramatsu, et al.. (2007). Early initiation of L‐dopa therapy enables stable development of executive function in tetrahydrobiopterin (BH4) deficiency. Developmental Medicine & Child Neurology. 49(5). 372–376. 3 indexed citations
16.
Breier, Alan, et al.. (2001). Nizatidine may ameliorate weight gain during olanzapine treatment. European Neuropsychopharmacology. 11. S279–S279. 2 indexed citations
17.
Itoh, Takashi, Mitsuyo Kondo, Yoko Tanaka, et al.. (2001). Novel Betacellulin Derivatives. Journal of Biological Chemistry. 276(44). 40698–40703. 7 indexed citations
18.
Tanaka, Yoko, et al.. (2000). A Study of Dwelling Life Education for the Viewpoint of Disaster Prevention. Journal of home economics. 51(2). 171–180. 1 indexed citations
19.
Tanaka, Yoko & Hector F. DeLuca. (1984). Rat renal 25-hydroxyvitamin D3 1- and 24-hydroxylases: their in vivo regulation. American Journal of Physiology-Endocrinology and Metabolism. 246(2). E168–E173. 52 indexed citations
20.
Smith, Connie M., Hector F. DeLuca, Yoko Tanaka, & Kathryn R. Mahaffey. (1981). Effect of Lead Ingestion on Functions of Vitamin D and its Metabolites. Journal of Nutrition. 111(8). 1321–1329. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Keisuke Fukuo Breakdown of academic impact, for papers by Nunziata Morabito Breakdown of academic impact, for papers by Keizo Ohnaka Breakdown of academic impact, for papers by William G. Christen Breakdown of academic impact, for papers by Ken‐ichi Aihara Breakdown of academic impact, for papers by H. Karimi Kinyamu Breakdown of academic impact, for papers by A. Louis Southren Breakdown of academic impact, for papers by Gary M. Leong Breakdown of academic impact, for papers by Paul E. Kroeger Breakdown of academic impact, for papers by Mikiko Ito
Rankless by CCL
2026